Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction.

MLA

Rieger, Angela C., et al. “Growth Hormone-Releasing Hormone Agonists Ameliorate Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction.” Proceedings of the National Academy of Sciences of the United States of America, vol. 118, no. 4, Jan. 2021. EBSCOhost, https://doi.org/10.1073/pnas.2019835118.

APA

Rieger, A. C., Bagno, L. L., Salerno, A., Florea, V., Rodriguez, J., Rosado, M., Turner, D., Dulce, R. A., Takeuchi, L. M., Kanashiro-Takeuchi, R. M., Buchwald, P., Wanschel, A. C. B. A., Balkan, W., Schulman, I. H., Schally, A. V., & Hare, J. M. (2021). Growth hormone-releasing hormone agonists ameliorate chronic kidney disease-induced heart failure with preserved ejection fraction. Proceedings of the National Academy of Sciences of the United States of America, 118(4). https://doi.org/10.1073/pnas.2019835118

Chicago

Rieger, Angela C, Luiza L Bagno, Alessandro Salerno, Victoria Florea, Jose Rodriguez, Marcos Rosado, Darren Turner, et al. 2021. “Growth Hormone-Releasing Hormone Agonists Ameliorate Chronic Kidney Disease-Induced Heart Failure with Preserved Ejection Fraction.” Proceedings of the National Academy of Sciences of the United States of America 118 (4). doi:10.1073/pnas.2019835118.